Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review

被引:66
|
作者
Gerestein, Cornelis G. [1 ,3 ]
Damhuis, Ronald A. M. [2 ]
Burger, Curt W. [3 ]
Kooi, Geertruida S. [1 ]
机构
[1] Albert Schweitzer Hosp, Dept Obstet & Gynecol, Dordrecht, Netherlands
[2] Rotterdam Canc Registry, Rotterdam, Netherlands
[3] Univ Med Ctr, Daniel Den Hoed Erasmus MC, Dept Obstet & Gynecol, Div Gynecol Oncol, Rotterdam, Netherlands
关键词
Postoperative mortality; 30-day mortality; Ovarian cancer; Primary cytoreductive surgery; Advanced stage; PRIMARY PERITONEAL CANCER; NEOADJUVANT CHEMOTHERAPY; SURGICAL CYTOREDUCTION; GYNECOLOGIC ONCOLOGISTS; PRIMARY DEBULKING; BOWEL RESECTION; FALLOPIAN-TUBE; ELDERLY-WOMEN; CARCINOMA; SURVIVAL;
D O I
10.1016/j.ygyno.2009.03.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Accurate estimation of the risk of postoperative mortality (POM) is essential for the decision whether or not to perform cytoreductive surgery in a patient with advanced stage ovarian cancer. To ascertain modern reference figures, a systematic review of studies reporting POM after primary cytoreductive surgery for advanced stage epithelial ovarian cancer (EOC) was performed. Materials and methods. A Medline search was performed to retrieve papers on primary cytoreductive surgery for advanced stage EOC. Twenty-three papers met the inclusion criteria and were reviewed. Results. According to population-based studies, POM after primary cytoreductive surgery for EOC is 3.7% on average. Single centre studies report an average rate of 2.5%. The overall mean POM is 2.8%. POM is more frequent for elderly women and after extensive procedures. Accurate information on age-specific and procedure-specific rates could not be obtained. Conclusion. POM rates after surgery for EOC are satisfactorily low. There is a clear need for reliable reference figures for mortality after debulking surgery in the elderly. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:523 / 527
页数:5
相关论文
共 50 条
  • [21] Trends in Mortality After Primary Cytoreductive Surgery for Ovarian Cancer: A Systematic Review and Metaregression of Randomized Clinical Trials and Observational Studies
    Di Donato, Violante
    Kontopantelis, Evangelos
    Aletti, Giovanni
    Casorelli, Assunta
    Piacenti, Ilaria
    Bogani, Giorgio
    Lecce, Francesca
    Panici, Pierluigi Benedetti
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (06) : 1688 - 1697
  • [22] Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer
    Kim, Myeong-Seon
    Baek, Seung Hun
    Noh, Joseph J.
    Shim, Jung In
    Kang, Jun Hyeok
    Jeong, Soo Young
    Choi, Chel Hun
    Kim, Tae-Joong
    Lee, Jeong-Won
    Lee, Yoo-Young
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] ASSOCIATIONS BETWEEN MOLECULAR SUBTYPES AND POSTOPERATIVE COMPLICATIONS AFTER PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED STAGE HIGH-GRADE SEROUS OVARIAN CANCER
    Torres, D.
    Kumar, A.
    Bakkum-Gamez, J.
    Langstraat, C.
    Goode, E.
    Cliby, W.
    Wang, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1693 - 1693
  • [24] Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study
    Jiang, Caixia
    Liu, Yingwei
    Tang, Junying
    Li, Zhengyu
    Min, Wenjiao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] ASSOCIATIONS BETWEEN MOLECULAR SUBTYPES AND POSTOPERATIVE COMPLICATIONS AFTER PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED STAGE HIGH-GRADE SEROUS OVARIAN CANCER
    Torres, D.
    Kumar, A.
    Bakkum-Gamez, J.
    Langstraat, C.
    Goode, E.
    Cliby, W.
    Wang, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 548 - 548
  • [26] Peroperative scoring systems for predicting the outcome of cytoreductive surgery in advanced-stage ovarian cancer - A systematic review
    Engbersen, M. P.
    Lahaye, M. J.
    Lok, C. A. R.
    Koole, S. N.
    Sonke, G. S.
    Beets-Tan, R. G. H.
    Van Driel, W. J.
    EJSO, 2021, 47 (08): : 1856 - 1861
  • [27] Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer
    Sinukumar, Snita
    Damodaran, Dileep
    Ray, Mukurdipi
    Mehta, Sanket
    Paul, Lista
    Bhatt, Aditi
    EJSO, 2021, 47 (06): : 1427 - 1433
  • [28] Age-Associated Risk of 90-Day Postoperative Mortality After Cytoreductive Surgery for Advanced Ovarian Cancer
    Kumar, Seema
    Hossain, Jobayer
    Inge, Thomas
    Balagopal, P. Babu
    JAMA SURGERY, 2019, 154 (07) : 669 - 671
  • [29] ROLE OF TERTIARY CYTOREDUCTIVE SURGERY IN RECURRENT EPITHELIAL OVARIAN CANCER: SYSTEMATIC REVIEW AND METANALYSIS
    Guida, F.
    Fagotti, A.
    Grossi, A.
    Vascone, C.
    Bizzarri, N.
    Ghirardi, V.
    Boccia, S.
    Scambia, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A136 - A137
  • [30] Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis
    Kengsakul, Malika
    Nieuwenhuyzen-de Boer, Gatske M.
    Udomkarnjananun, Suwasin
    Kerr, Stephen J.
    Niehot, Christa D.
    van Beekhuizen, Heleen J.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (04)